Clinical Trial Update: Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 study of ATLCAR.CD138 cells for relapsed/refractory multiple myeloma, with the study listed as active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• ATLCAR.CD138 (ATLCAR.CD138 CAR-T cells)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Multiple Myeloma, Immune System Diseases | Phase 1 | Status: ACTIVE_NOT_RECRUITING